We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAST
3201
DELISTED
Carrols Restaurant Group, Inc.
TAST
-177,728
Closed -$1.06M
AEL
3202
DELISTED
American Equity Investment Life Holding Company
AEL
-55,875
Closed -$1.76M
YTEN
3203
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
-1,574
Closed -$474K
RMGCU
3204
DELISTED
RMG Acquisition Corp. III Unit
RMGCU
-700,505
Closed -$6.97M
GGE
3205
DELISTED
Green Giant Inc. Common Stock
GGE
-105,485
Closed -$215K
ARRWU
3206
DELISTED
Arrowroot Acquisition Corp. Unit
ARRWU
-955,795
Closed -$9.5M
SCTL
3207
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
-65,107
Closed -$182K
NGM
3208
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
-45,577
Closed -$1.32M
PARAP
3209
DELISTED
Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock
PARAP
-50,000
Closed -$3.36M
FSR
3210
DELISTED
Fisker Inc.
FSR
-165,124
Closed -$2.84M
ROSS.U
3211
DELISTED
Ross Acquisition Corp II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
ROSS.U
-1,000,103
Closed -$9.96M
KRTX
3212
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-45,861
Closed -$5.51M
LCAHU
3213
DELISTED
Landcadia Holdings IV, Inc. Units
LCAHU
-2,000,000
Closed -$19.8M
SLACU
3214
DELISTED
Social Leverage Acquisition Corp I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant
SLACU
-200,000
Closed -$1.99M
LCAAU
3215
DELISTED
L Catterton Asia Acquisition Corp Units
LCAAU
-750,000
Closed -$7.46M
GMBL
3216
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
-2
Closed -$909K
FLME.U
3217
DELISTED
Flame Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one Warrant
FLME.U
-597,396
Closed -$5.93M
IMGN
3218
DELISTED
Immunogen Inc
IMGN
-523,087
Closed -$4.24M
CPTK.U
3219
DELISTED
Crown PropTech Acquisitions Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CPTK.U
-823,489
Closed -$8.19M
HHLA.U
3220
DELISTED
HH&L Acquisition Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
HHLA.U
-121,121
Closed -$1.22M
NVTA
3221
DELISTED
Invitae Corporation
NVTA
-752,679
Closed -$28.8M
NSTB
3222
DELISTED
Northern Star Investment Corp. II
NSTB
-149,965
Closed -$1.5M
DISAU
3223
DELISTED
Disruptive Acquisition Corporation I Unit
DISAU
-1,100,000
Closed -$10.9M
BYTSU
3224
DELISTED
BYTE Acquisition Corp. Units
BYTSU
-1,250,000
Closed -$12.5M
CTG
3225
DELISTED
Computer Task Group, Inc.
CTG
-26,208
Closed -$250K

Similar funds

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.